Assessment of adherence to, and persistence with, an electromechanical autoinjector for subcutaneous interferon beta-1a injections for multiple sclerosis treatment over 3 years.
Expert opinion on drug delivery（2023）
摘要
People living with MS were highly adherent to use of the RebiSmart® device, with higher persistence generally observed for older and/or male individuals.
更多查看译文
关键词
Adherence,interferon beta-1a,multiple sclerosis,persistence,RebiSmart((R)) device
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要